Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/25 16:05 | 5/20/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Militello John | NJ | O | See Rema | 3 | S | -12 | 6.77 | 0 | -2 | 65 | D | |||||||||||||||
5/22/25 16:05 | 5/20/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Schwartz Jonathan David | NJ | O | See Rema | 2 | S | -15 | 6.50 | 0 | -2 | 236 | D | |||||||||||||||
5/22/25 16:05 | 5/20/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Patel Kinnari | NJ | O | See Rema | 3 | S | -113 | 4.87 | 0 | -23 | 576 | D | |||||||||||||||
5/22/25 16:05 | 5/20/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Shah Gaurav | NJ | DO | CEO | 3 | S | -140 | 5.40 | 0 | -26 | 1,199 | D | |||||||||||||||
5/22/25 16:05 | 5/20/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Wilson Martin | NJ | O | GC | 2 | S | -10 | 6.50 | 0 | -2 | 150 | D | |||||||||||||||
4/8/25 16:06 | 4/4/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Ondrey Aaron | NJ | O | CFO | 1 | S | -40 | 5.29 | 0 | -7 | 130 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |